Global Market for Nanoparticles Instrumentation to Reach About $7.8 Billion by 2019; Particle Characterization to Witness Highest CAGR Growth of 8.4%
October 13, 2014
Wellesley, Mass., October 13, 2014 –BCC Research (www.bccresearch.com) reveals in its new report, GLOBAL MARKETS FOR NANOPARTICLE SIZE ANALYSIS INSTRUMENTATION IN THE LIFE SCIENCES, the global market for nanoparticles instrumentation in life sciences is expected to reach to about $7.8 billion by 2019, a compound annual growth rate (CAGR) of 5.7% for the five-year period, 2014 to 2019. Particle characterization will record the highest CAGR growth of 8.4% for the forecast period.
The biggest increase will come in the area of supplying instrumentation to companies in the pharmaceutical and biotechnology segments. As nanoparticle drug products complete clinical trials and gain U.S. Food and Drug Agency (FDA) market approval, there will be an increase in the requirement for analytical equipment to support production of these drugs. Growing health concerns in developing countries are expected to continue to contribute substantially to market growth for biopharmaceuticals. Sustained growth is expected in emerging geographies, driven by the health awareness of the burgeoning middle class in emerging countries such as India, China, Brazil, and Russia.
“At present, the U.S. holds the largest number of patents in the nanoparticle area,” says BCC Research biotechnology analyst, Jackson Highsmith. “This is largely due to the early commercialization of some nanoparticle products by U.S. companies. It also reflects a larger contribution to the research and development of new ideas by American companies than by those in most other countries.”
GLOBAL MARKETS FOR NANOPARTICLE SIZE ANALYSIS INSTRUMENTATION IN THE LIFE SCIENCES provide an overview of the various types of instrumentation currently on the market for nanoparticle analysis and highlight new advances in this area. This report projects the trend that the life sciences nanoparticle analytical instrumentation business will experience over the projected five-year period of 2014 to 2019. It also projects the eventual recovery of the business to more moderate growth rates.

Editors and reporters who wish to speak with the analyst should contact Steven Cumming at steven.cumming@bccresearch.com.
Global Markets for Nanoparticle Size Analysis Instrumentation in the Life Sciences( BIO114B )
Publish Date: Aug 2014
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Cell Biology
- Biomarker Deals Accelerate: Strategic Alliances Reshape Life Sciences Innovation
- China’s DNA Sequencing Market to Grow at 21.5% CAGR by 2030
- mRNA Market Forecast: Small Decline of -0.04% CAGR by 2030
- Molecular Diagnostics Market to Grow at 13.1% CAGR Through 2030
- Biotech Equipment Market Projected to Reach $143.9 Billion Globally by 2030
Reports from Cell Biology
Recent News
- Global Hyaluronic Acid in Healthcare Market to Reach $10.5 Billion by 2030
- Global Patient Monitoring Market to Reach $55.8 Billion by End of 2030
- Global Market for Biological and Medical Imaging Reagents Set to Surge to $40.1 Billion by 2030
- Targeted Alpha Therapies Market to Grow at 44% CAGR Globally by 2030
- Global Anti-Parkinson's Drugs Markets Projected to Reach $9.2 Billion by the End of 2030
